Bradley Merrill Thompson Quoted in “NY AG Puts Mobile Health App Makers on Notice That FDA, FTC Not Only Enforcers of Health Claims”

Inside Health Policy

Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in Inside Health Policy, in “NY AG Puts Mobile Health App Makers on Notice That FDA, FTC Not Only Enforcers of Health Claims,” by David Lim. (Read the full version – subscription required.)

Following is an excerpt:

“This is interesting, because yet again we have an agency other than FDA weighing in on what it thinks is misleading advertising. Over the last several years, we've seen the FTC pursue mobile app companies on the basis of unsupported claims in the medical realm. Indeed it has pursued claims that would likely fall under FDA regulation. But the federal government doesn't have a monopoly on regulating advertising, even for health-related products,” Bradley Merrill Thompson, attorney at Epstein, Becker & Green, told IHP in an email.